Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-02
1996-06-25
Higel, Floyd D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31415, C07D23364, C07D23368, C07D23384
Patent
active
055300170
ABSTRACT:
Angiotensin II receptor antagonists having the formula: ##STR1## which are useful in regulating hypertension and in the treatment of congestive heart failure, renal failure, and glaucoma, pharmaceutical compositions including these antagonists, and methods of using these compounds to produce angiotensin II receptor antagonism in mammals.
REFERENCES:
patent: 3826836 (1974-07-01), Buchel et al
patent: 4340598 (1982-07-01), Furukawa et al.
patent: 4355040 (1982-10-01), Furukawa et al.
patent: 4447431 (1984-05-01), Sallmann
patent: 4767752 (1988-08-01), Ishii et al.
Girard Gerald R.
Hempel Judith
Hill David T.
Samanen James
Weinstock Joseph
Higel Floyd D.
Lentz Edward T.
McCarthy Mary E.
SmithKline Beecham Corp
Venetianer Stephen
LandOfFree
Method of antagonizing angiotensin II receptors in mammals using does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of antagonizing angiotensin II receptors in mammals using, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of antagonizing angiotensin II receptors in mammals using will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2189108